The “m6A writer” METTL3 and the “m6A reader” IGF2BP2 regulate cutaneous T‐cell lymphomas progression via CDKN2A-Reference-Cited by-同舟云学术

The “m6A writer” METTL3 and the “m6A reader” IGF2BP2 regulate cutaneous T‐cell lymphomas progression via CDKN2A

Published:2022-04-29 Issue:4 Volume:40 Page:567-576
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Wang Xinchen¹,Hu Maogui¹,Yu Lu¹,Wang Xiaoyan¹,Jiang Xinlu¹,Zhang Guihong²,Ding Kaiyang¹^ORCID

Affiliation:

1. Department of Hematology The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei China

2. Department of Pathology The First Affiliated Hospital of Anhui Medical University Hefei China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3005

Reference35 articles.

1. An overview of cutaneous T cell lymphomas

2. Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma

3. Topical resiquimod can induce disease regression and enhance T‐cell effector functions in cutaneous T‐cell lymphoma. Blood;Rook AH;J Am Soc Hematol,2015

4. Purification and cDNA cloning of the AdoMet‐binding subunit of the human mRNA (N6‐adenosine)‐methyltransferase;Bokar JA;RNA,1997

5. A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on the role of RNA methylation in aging-related diseases;International Journal of Biological Macromolecules;2024-01

2. The potential role of RNA modification in skin diseases, as well as the recent advances in its detection methods and therapeutic agents;Biomedicine & Pharmacotherapy;2023-11

3. Research Progress of m6A RNA Methylation in Skin Diseases;BioMed Research International;2023-04-19

4. N6-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis;Advances in Experimental Medicine and Biology;2023

5. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation;Frontiers in Oncology;2022-12-22